Home/ Stocks/ SLP

Simulations Plus, Inc.

SLP XNAS

$13.15 +0.53 (+4.19%) ▲ 15-min delayed

Open

$13.20

High

$13.30

Low

$12.98

Volume

76.4K

Market Cap

$254.85M

About Simulations Plus, Inc.

Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

Sector: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN Employees: 213 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$18.42M	$676.0K	$0.03
FY 2025	$79.18M	$-64,718,000	$-3.22
Q3 2025	$20.36M	$-67,317,000	$-3.35
Q2 2025	$22.43M	$3.07M	$0.15

Related Market News

No specific coverage for SLP yet. Check out our latest market news or earnings calendar.

Get SLP Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Simulations Plus, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.